ICH E2D

E559691

ICH E2D is an International Council for Harmonisation guideline that provides standards for post-approval safety data management, including the collection, evaluation, and reporting of safety information for marketed medicinal products.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf ICH guideline
pharmacovigilance guideline
abbreviationOf International Council for Harmonisation Guideline E2D NERFINISHED
addresses definitions related to post-approval safety data
expedited reporting time frames
follow-up of safety reports
literature case reporting
minimum information for a valid individual case safety report
reporting of safety information from compassionate use or named-patient programs
reporting of safety information from non-interventional studies
reporting of safety information from post-authorization studies
reporting of safety information from registries
reporting of safety information from special situations such as pregnancy and overdose
unlisted and serious adverse reactions
appliesTo clinical trial safety reports after marketing authorisation
marketed medicinal products
post-marketing individual case safety reports
spontaneous reports of adverse drug reactions
covers company and regulatory responsibilities for safety data management
data quality and completeness in safety reports
electronic and paper-based safety reporting
handling of duplicate reports
defines criteria for expedited reporting of individual case safety reports
standards for collection of post-marketing safety data
standards for evaluation of post-marketing safety data
standards for reporting of post-marketing safety data
domain drug safety regulation
pharmacovigilance
focusesOn expedited reporting of safety information
post-approval safety data management
safety information for marketed medicinal products
fullName ICH Harmonised Tripartite Guideline E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting NERFINISHED
issuedBy International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NERFINISHED
objective to harmonise international standards for post-approval safety reporting
to improve consistency of expedited safety reporting across regions
to support protection of public health through timely safety communication
regulatoryRegion European Union NERFINISHED
ICH regions
Japan NERFINISHED
United States NERFINISHED
relatedTo ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting NERFINISHED
ICH E2B Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports NERFINISHED
ICH E2C Periodic Benefit-Risk Evaluation Report (PBRER) NERFINISHED
ICH E2E Pharmacovigilance Planning NERFINISHED
status harmonised guideline
usedBy marketing authorisation holders
pharmaceutical companies
regulatory authorities

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.